While we delineated the central effect of GLP1 under homeostatic conditions, it was important to further explore the effects of GLP1 in the hedonic pathway as it is gaining popularity as a therapeutic intervention in treatment of obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.